← Return to ANA Titer 1:1280 pattern homogeneous and speckled o/w negative work-up

Discussion
Comment receiving replies
@trspac

@slkanowitz - Hello. Thank you for this information. All the tests you mentioned above except the skeletal muscle enzymes and EBV to include EA have been completed and normal/negative. I will have my internist draw those. Will not bother mentioning to Rheumatologist since was matter of fact that he does not know why I am having what he states are atypical symptoms after ruling out sjogrens, lupus and CTD. He did start me on pilocarpine which I am taking twice daily now and will max at 3 times a day. A small amount of sputum is being produced only. My gums are receding from my dry mouth. I carry around with me all the dry mouth products and use lozenges. Since I have associated TMJ pain xylitol gum is a no for now. I will gather enough strength to advocate for myself again. Just an exhausting couple of months and trying to regroup with a new starting point. I am just so frustrated. Thank you again for the information. Will write in my log for future follow up testing.

Jump to this post


Replies to "@slkanowitz - Hello. Thank you for this information. All the tests you mentioned above except the..."

https://avisetest.com/patient/ctd/
Tests for 23 biomarkers and looks like it tests for 8 autoimmune disorders. From the site:

Patented CB‑CAPs biomarkers
AVISE Lupus, a component of AVISE CTD, is the only validated test that uses patented biomarkers called CB-CAPs that have been proven to outperform standard diagnosis laboratory testing in the detection of SLE.

CB-CAPs identifies significantly more lupus patients that would otherwise appear negative with conventional markers. CB-CAPs are an innovative way to measure abnormality in your immune system that is unique to lupus.

Using CB-CAPs and other lupus-associated markers, AVISE CTD employs an advanced two-tier algorithm and proprietary Index Value to help turn isolated data points into actionable information. The index result is plotted on a spectrum associated with the likelihood of the presence of lupus.